To view this email as a web page, click here.
 
CHECK OUT OUR LATEST ISSUE
 
Medical Economics cover
Everything Pharmacists Need to Know About DIR Reform
Meaningful changes to DIR fees are on the horizon—will pharmacies see an increase in reimbursements?
More
 
Pediatric Patients Present Unique Challenges to Pharmacists
Board-certified pharmacists are better prepared to deal with pediatric patients than others.
Here’s why
 
Apalutimide for Prostate Cancer: What to Know
FDA approves apalutamide for castration-resistant prostate cancer.
More
 
View the full issue here.
 
RELATED ARTICLES
 
DIR Fees: Just One of Many Reimbursement Battles
New Migraine Meds Pharmacists Need to Know About
How Pharmacists Can Protect Kids from Dangerous Medications
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.